Hyperfine Inc Ordinary Shares - Class A HYPR 深 滬
等待開盤 09-04 09:30:00 美东时间
1.12
-0.090
-7.44%
華盛通- 最 高1.20
- 今 開1.20
- 成交量 34.39万股
- 最 低 1.08
- 昨 收 1.21
- 總市值 8718.07万
- 52周最高 1.90
- 市盈率 靜 --
- 換手率 0.44%
- 52周最低 0.5327
- 委 比 -73.96%
- 總股本 7783.99万
- 歷史最高 16.61
- 量 比 1.89
- 振 幅 9.92%
- 歷史最低 0.5327
- 每 手 1
- 風險率 0.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Hyperfine Secures CE and UKCA Approvals For Optive AI, Advancing Image Quality For Portable MRI Across Europe
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European marketsHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has
09-02 20:16
Hyperfine Inc. Reports Strong Growth Amid Strategic Advances
Hyperfine Inc. (($HYPR)) has held its Q2 earnings call. Read on for the main hi...
09-01 08:23
美股大行评级 | 潜在涨幅仍有782.74%！Passage BIO遭Canaccord Genuity下调目标价至67美元，维持"买入"评级
今日重点评级关注：Northland Capital Markets：维持BrainsWay"跑赢大市"评级，目标价从15美元升至19美元；Lake Street：维持Hyperfine"买入"评级，目标价从1.5美元升至2美元
08-15 09:30
Lake Street Maintains Buy on Hyperfine, Raises Price Target to $2
Lake Street analyst Frank Takkinen maintains Hyperfine (NASDAQ:HYPR) with a Buy and raises the price target from $1.5 to $2.
08-15 00:48
Hyperfine shares are trading higher. The company reported Q2 financial results.
Hyperfine shares are trading higher. The company reported Q2 financial results.
08-14 23:51
Hyperfine Affirms FY2025 Sales Guidance of $14.179M-$15.468M vs $14.193M Est
Hyperfine (NASDAQ:HYPR) affirms FY2025 sales outlook from $14.179 million-$15.468 million to $14.179 million-$15.468 million vs $14.193 million estimate.
08-14 04:07
Hyperfine Q2 EPS $(0.12), Inline, Sales $2.696M Miss $3.000M Estimate
Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year. The
08-14 04:06
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Hyperfine Enrolls First Patients In PRIME Study Aimed St Accelerating Adoption Of AI-Powered Portable MRI In Emergency Departments
The real-world study will assess the clinical and operational impact of portable MRI across diverse patient types in ED settings.
07-31 20:22
Hyperfine shares are trading higher after the company announced the launch of Optive AI software.
Hyperfine shares are trading higher after the company announced the launch of O...
07-23 22:50
